Nasdaq:OBSV
#ObsEva #Announces #Progress #Cost #Reduction #Initiatives Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million savings expected from...
Hi, what are you looking for?
#ObsEva #Announces #Progress #Cost #Reduction #Initiatives Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million savings expected from...